Year |
Citation |
Score |
2020 |
Bacon NA, Larre I, Lawag AA, Merritt C, Smith M, Rosolen M, Sollars VE. Low dose HSP90 inhibition with AUY922 blunts rapid evolution of metastatic and drug resistant phenotypes induced by TGF-β and paclitaxel in A549 cells. Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie. 129: 110434. PMID 32768937 DOI: 10.1016/J.Biopha.2020.110434 |
0.324 |
|
2017 |
Lawag AA, Napper JM, Hunter CA, Bacon NA, Deskins S, El-Hamdani M, Govender SL, Koc EC, Sollars VE. HSP90 Inhibition and Cellular Stress Elicits Phenotypic Plasticity in Hematopoietic Differentiation. Cellular Reprogramming. PMID 28910138 DOI: 10.1089/cell.2017.0001 |
0.698 |
|
2013 |
Napper J, Sollars VE. Abstract B16: Phenotypic plasticity in the EML cell culture system as a result of HSP90 inhibition Cancer Research. 73. DOI: 10.1158/1538-7445.Cec13-B16 |
0.49 |
|
2011 |
Zeng WP, Sollars VE, Belalcazar Adel P. Domain requirements for the diverse immune regulatory functions of foxp3. Molecular Immunology. 48: 1932-9. PMID 21737139 DOI: 10.1016/J.Molimm.2011.05.023 |
0.334 |
|
2011 |
Bhullar J, Sollars VE. YBX1 expression and function in early hematopoiesis and leukemic cells. Immunogenetics. 63: 337-50. PMID 21369783 DOI: 10.1007/S00251-011-0517-9 |
0.766 |
|
2011 |
Varney ME, Buchanan JT, Dementieva Y, Hardman WE, Sollars VE. A high omega-3 fatty acid diet has different effects on early and late stage myeloid progenitors. Lipids. 46: 47-57. PMID 21038084 DOI: 10.1007/S11745-010-3491-3 |
0.715 |
|
2010 |
Napper JM, Sollars VE. 17-N-Allylamino-17-demethoxygeldanamycin induces a diverse response in human acute myelogenous cells. Leukemia Research. 34: 1493-500. PMID 20646760 DOI: 10.1016/J.Leukres.2010.05.024 |
0.692 |
|
2010 |
Kelly SE, Di Benedetto A, Greco A, Howard CM, Sollars VE, Primerano DA, Valluri JV, Claudio PP. Rapid selection and proliferation of CD133+ cells from cancer cell lines: chemotherapeutic implications. Plos One. 5: e10035. PMID 20386701 DOI: 10.1371/Journal.Pone.0010035 |
0.419 |
|
2010 |
Fan J, Eastham L, Varney ME, Hall A, Adkins NL, Chetel L, Sollars VE, Georgel P, Niles RM. Silencing and re-expression of retinoic acid receptor beta2 in human melanoma. Pigment Cell & Melanoma Research. 23: 419-29. PMID 20374520 DOI: 10.1111/J.1755-148X.2010.00702.X |
0.707 |
|
2010 |
Bhullar J, Sollars VE. Abstract 2964: YB-1 expression in early hematopoiesis and leukemic cells Cancer Research. 70: 2964-2964. DOI: 10.1158/1538-7445.Am10-2964 |
0.766 |
|
2009 |
Varney ME, Hardman WE, Sollars VE. Omega 3 fatty acids reduce myeloid progenitor cell frequency in the bone marrow of mice and promote progenitor cell differentiation. Lipids in Health and Disease. 8: 9. PMID 19296839 DOI: 10.1186/1476-511X-8-9 |
0.749 |
|
2007 |
Wilson KR, Napper JM, Denvir J, Sollars VE, Yu HD. Defect in early lung defence against Pseudomonas aeruginosa in DBA/2 mice is associated with acute inflammatory lung injury and reduced bactericidal activity in naive macrophages. Microbiology (Reading, England). 153: 968-79. PMID 17379707 DOI: 10.1099/Mic.0.2006/002261-0 |
0.65 |
|
2006 |
Sollars VE, Pequignot E, Rothstein JL, Buchberg AM. Analysis of expansion of myeloid progenitors in mice to identify leukemic susceptibility genes. Mammalian Genome : Official Journal of the International Mammalian Genome Society. 17: 808-21. PMID 16897342 DOI: 10.1007/S00335-006-0017-7 |
0.419 |
|
2005 |
Sollars VE. Epigenetic modification as an enabling mechanism for leukemic transformation. Frontiers in Bioscience : a Journal and Virtual Library. 10: 1635-46. PMID 15769653 DOI: 10.2741/1647 |
0.31 |
|
2005 |
Sollars V. The Epigenomic Viewpoint on Cellular Differentiation of Myeloid Progenitor Cells as it Pertains to Leukemogenesis Current Genomics. 6: 137-143. DOI: 10.2174/1389202053971983 |
0.502 |
|
2003 |
Sollars V, Lu X, Xiao L, Wang X, Garfinkel MD, Ruden DM. Evidence for an epigenetic mechanism by which Hsp90 acts as a capacitor for morphological evolution. Nature Genetics. 33: 70-4. PMID 12483213 DOI: 10.1038/Ng1067 |
0.312 |
|
Show low-probability matches. |